CPhI Panel to Analyse New Industry Perspectives and Innovations Ahead of Predictive 2014 Annual Report

PR57371

AMSTERDAM, July 16, 2014/ PRN=KYODO JBN / --

New panel additions Patheon, Almac and Arevepharma to provide global insights

from the contract services sector

CPhI expert panel members for 2014:

1. Prabir Basu, President at Pharma Manufacturing

2. Girish Malhotra, President & Founder, Epcot International

[http://www.pharmaevolution.com/bloggers.asp#Girish_Malhotra ]

3. Hedley Rees, Managing Director at PharmaFlow Ltd

4. Sam Venugopal, Director in the Healthcare Practice at PWC

5. William Botha, Consultant and Founder Interlean

6. Emil Ciurczak, President at Doramaxx Consulting

7. Dilip G Shah, CEO of Vision Consulting Group and a regulatory expert

8. Vijay Shah, COO at Piramal Enterprises and pharma business lead

9. Hendrik Baumann, CEO of Arevipharma

10. Lukas Utiger, President of Fine Chemicals and Integrated Offering at DSM

11. Alan Armstrong  (CEO) and Douglas Cookson (VP corporate marketing), Almac

12. Brian Carlin, Director Open Innovation at FMC

13. Ali Afnan, President at Step Change Pharma

CPhI Worldwide [http://www.cphi.com/ ], organised by UBM Live, has announced

its full line up of confirmed expert industry panel members for 2014, building

on the huge success of the CPhI annual report launched at CPhI Worldwide in

October 2013.  

     (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

This year's panel sees the return of ten thought leaders with the addition of

three new members, covering the entire pharmaceutical supply chain from R&D

through to finished products, regulatory requirements and economic

implications. Additionally, this year panel members are utilising their market

insights and analysis year round in the CPhI Pharma Insights series, which

cover individual topics and developments across the industry - including the

released R&D, manufacturing and Turkey reports, with a United States report due

out imminently.

The new panel members are all from the contract manufacturing arena, with

heavyweights Alan Armonstrong (CEO) and Douglas Cookson (VP corporate

marketing) from Almac. Hendrik Baumann, the current CEO of Arevipharma,

leverages his expertise within the German market and across API manufacturing.

Lukas Utiger - president of Fine Chemicals and Integrated Offering at DSM -

will lend his insights in the commercialization of pharmaceuticals.

Collectively they provide a global overview of outsourcing with Almac and

Arevipharma focusing on the international market from a European stance and DSM

from a US perspective.

The returning members feature expertise across API and manufacturing

efficiencies (Girish Malhotra) to quality systems and supply chain activities

(Sam Venugopal), with insights also provided from some of the sectors biggest

names and innovators, like Piramal's Vijay Shah. Across supply chain issues,

the panel will leverage the knowledge of Hedley Rees, whilst Prabir Basu,

formerly of the National Institute for Pharmaceutical Technology and Education

(NIPTE), will focus on the industry's approach to innovation.

Regulatory expert, predominantly focussed on the Indian market, Dilip Shah also

returns covering the intellectual property rules around innovation. Brian

Carlin, who chairs IPEC Americas Excipient Qbd Committee, is also returning. He

serves as the director of Open innovation at FMC and received the IPEC One

World Regulatory Excellence Award in 2014. The winner of several FDA

Commissioner Awards, Dr. Ali Afnan is another well-respected industry

influencer and was a key contributor to the drafting and finalising of the

current FDA Process Validation Guidance.

Emil Ciurczak, previously a member of the FDA's PAT committee and president of

Doramaxx Consulting

[http://www.linkedin.com/search?search=&company=Doramaxx+Consulting&sortCriteria

=R&keepFacets=true&trk=prof-exp-company-name ] draws upon his expertise across

PAT, QbD and spectroscopy. Finally, William Botha, a respected trainer and

mentor in manufacturing is also retuning to the panel; he is fluent in FDA

regulations, including GDP and GMP.

Last year's report examined major issues and developments across the industry

including regulatory challenges from a globalised industry, cost savings

through QbD and PAT, to the effect breakthrough drugs like ADCs will have on

overcoming future disease pathologies.

"The 2013 report was hugely successful with our experts providing insights into

how the industry will adapt in the near future. This year we have been able to

see the progress the industry has made along with the new challenges and

threats ahead. Our experts will examine future potential breakthrough drugs,

regulatory risks and supply chain issues. This year we also have representation

from leading global CDMO players, Patheon, Almac and Arevipharma- adding a

further depth of perspectives and providing a completely holistic picture of

the global pharma landscape." commented Chris Kilbee, Group Director Pharma at

CPhI.

The 2014 annual report features a collection of in depth essays from each panel

member - with experts again given carte blanche to prophesize how the industry

will look and operate in the future from both an economic and practical

perspective.

Kilbee added, "I am very pleased that we have been able to include in our panel

many of the major figures in the industry, as they provide hundreds of years of

experience both individually and collectively. The panel's ability to provide a

realistic approach to problem solving, coupled with an international outlook is

essential in advancing market dynamics."

For more information, please contact: cphi@ubm.com  

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical

supply chain from drug discovery to finished dosage. Through exhibitions,

conferences and online communities, CPhI brings together more than 100,000

pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, Korea,

China, India, Japan, Southeast Asia, Istanbul, Russia and South America and

co-locates with ICSE for contract services, P-MEC for machinery, equipment &

technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI

provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also includes; CPhI South

America (5-7 August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI, ICSE

Korea (2-3 September, 2014 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC

and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte- France); CPhI

and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai);

CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big

Sight Exhibition Centre- Tokyo). CPhI Russia and IPhEB (27-29 April, 2015 at

the VVC, Pavilion Nr 75, Moscow Russia); CPhI, P-MEC and Innopack South East

Asia (26-28 May, 2015 at the Jakarta International Expo- Jakarta, Indonesia);

CPhI Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and Exhibition

Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (23-25

June, 2014 at SNIEC- Shanghai, China)

About UBM Live

UBM Live connects people and creates opportunities for companies across five

continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:

Alex Heeley or Tristan Jervis    

De Facto Communications

T: +44(0)207-203-6745 / 6740

E: a.heeley@defacto.com / t.jervis@defacto.com

SOURCE: UBM Live